These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21977854)

  • 1. Progress in study on synergism and detoxification of Chinese medicine for glucocorticoid.
    Xie GQ; Wen CP; Fan YS
    J Tradit Chin Med; 2011 Sep; 31(3):163-8. PubMed ID: 21977854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Current situation of Chinese medicine in treating glucocorticoid-dependent idiopathic thrombocytopenic purpura].
    Chen Y; Li D
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Feb; 31(2):276-9. PubMed ID: 21425591
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of Jieduquyuzishen prescription-treated rat serum on the BAFF/BAFF-R signal pathway.
    Wu DH; Xu L; Wen CP; Xie GQ; Ji JJ; Pan JL; Jiao YF; Fan YS
    PLoS One; 2015; 10(2):e0118462. PubMed ID: 25689512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New developments in glucocorticoid therapy: selective glucocorticoid receptor agonists, nitrosteroids and liposomal glucocorticoids].
    Huisman AM; Jacobs JW; Buttgereit F; Bijlsma JW
    Ned Tijdschr Geneeskd; 2006 Mar; 150(9):476-80. PubMed ID: 16553045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Mechanisms of Glucocorticoids.
    Vandewalle J; Luypaert A; De Bosscher K; Libert C
    Trends Endocrinol Metab; 2018 Jan; 29(1):42-54. PubMed ID: 29162310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research on Chinese medicine pairs (IV)--Their compatibility effects].
    Li WX; Tang YP; Shi XQ; Guo JM; Liu P; Duan JA
    Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(24):4203-7. PubMed ID: 24791517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in the development of novel glucocorticoid receptor modulators.
    Berlin M
    Expert Opin Ther Pat; 2010 Jul; 20(7):855-73. PubMed ID: 20553093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress of Chinese medicine treatment of HAART-related toxic and side effect].
    Liu Y; Dong JP; Zou W; Gao GJ; Wang J
    Zhongguo Zhong Yao Za Zhi; 2013 Aug; 38(15):2527-9. PubMed ID: 24228553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside Rg1, a novel glucocorticoid receptor agonist of plant origin, maintains glucocorticoid efficacy with reduced side effects.
    Du J; Cheng B; Zhu X; Ling C
    J Immunol; 2011 Jul; 187(2):942-50. PubMed ID: 21666059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of glucocorticoid-like activity in traditional Chinese medicine used for the treatment of Duchenne muscular dystrophy.
    Courdier-Fruh I; Barman L; Wettstein P; Meier T
    Neuromuscul Disord; 2003 Nov; 13(9):699-704. PubMed ID: 14561491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Retrospective study on the dynamic development of Chinese medical syndrome types of gastric cancer].
    Jiang C; Lin SY; Zhao JL
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Jan; 33(1):44-6. PubMed ID: 23596785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in the study of therapeutic effects of traditional Chinese medicine and extracts in treating severe acute pancreatitis.
    Zhang XP; Shi Y; Zhang L
    JOP; 2007 Nov; 8(6):704-14. PubMed ID: 17993723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoid-induced leucine zipper? A perspective.
    Ayroldi E; Macchiarulo A; Riccardi C
    FASEB J; 2014 Dec; 28(12):5055-70. PubMed ID: 25205742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [GILZ (glucocorticoid-induced leucine zipper), a mediator of the anti-inflammatory and immunosuppressive activity of glucocorticoids].
    Riccardi C
    Ann Ig; 2010; 22(1 Suppl 1):53-9. PubMed ID: 20701225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research progress of drugs commonly used to anti-rheumatoid arthritis].
    Chi LQ; Zhou B; Gao WY; Liu Z
    Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(15):2851-8. PubMed ID: 25423821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylaxis of glucocorticoid-induced osteoporosis].
    Tanaka Y
    Clin Calcium; 2006 Nov; 16(11):1858-65. PubMed ID: 17079853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C; Buttgereit F
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung diseases.
    Newton R; Leigh R; Giembycz MA
    Pharmacol Ther; 2010 Feb; 125(2):286-327. PubMed ID: 19932713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A metabolic mechanism analysis of Fuzheng-Huayu formula for improving liver cirrhosis with traditional Chinese medicine syndromes.
    Song YN; Chen J; Cai FF; Lu YY; Chen QL; Zhang YY; Liu P; Su SB
    Acta Pharmacol Sin; 2018 Jun; 39(6):942-951. PubMed ID: 29072258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming glucocorticoid resistance: a new pathway from an ancient Chinese medicine?
    Krett N; Ma S
    Leuk Lymphoma; 2009 May; 50(5):689-90. PubMed ID: 19330651
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.